ES443825A1 - Procedimiento para la preparacion de d-homoroceto-pregna- nos. - Google Patents

Procedimiento para la preparacion de d-homoroceto-pregna- nos.

Info

Publication number
ES443825A1
ES443825A1 ES443825A ES443825A ES443825A1 ES 443825 A1 ES443825 A1 ES 443825A1 ES 443825 A ES443825 A ES 443825A ES 443825 A ES443825 A ES 443825A ES 443825 A1 ES443825 A1 ES 443825A1
Authority
ES
Spain
Prior art keywords
hydrogen
ketopregnanes
homo
image
narcosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES443825A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742461312 external-priority patent/DE2461312A1/de
Priority claimed from DE19752506688 external-priority patent/DE2506688A1/de
Application filed by Schering AG filed Critical Schering AG
Publication of ES443825A1 publication Critical patent/ES443825A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES443825A 1974-12-23 1975-12-23 Procedimiento para la preparacion de d-homoroceto-pregna- nos. Expired ES443825A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19742461312 DE2461312A1 (de) 1974-12-23 1974-12-23 D-homo-20-keto-pregnane und verfahren zu ihrer herstellung
DE19752506688 DE2506688A1 (de) 1975-02-14 1975-02-14 D-homo-19-nor-20-ketopregnane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ES443825A1 true ES443825A1 (es) 1977-05-01

Family

ID=25768157

Family Applications (1)

Application Number Title Priority Date Filing Date
ES443825A Expired ES443825A1 (es) 1974-12-23 1975-12-23 Procedimiento para la preparacion de d-homoroceto-pregna- nos.

Country Status (13)

Country Link
US (1) US4056633A (enExample)
JP (1) JPS5188953A (enExample)
AU (1) AU501685B2 (enExample)
CA (1) CA1051868A (enExample)
DD (1) DD123329A5 (enExample)
DK (1) DK138501C (enExample)
ES (1) ES443825A1 (enExample)
FR (1) FR2295739A1 (enExample)
GB (1) GB1538869A (enExample)
IL (1) IL48628A0 (enExample)
LU (1) LU74087A1 (enExample)
NL (1) NL7514976A (enExample)
SE (1) SE7514514L (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104306A (en) * 1976-05-05 1978-08-01 Abbott Laboratories 12A-Deoxy chelocardin
US5439900A (en) * 1993-02-25 1995-08-08 Bukusoglu; Cuneyt Methods and compositions for providing analgesia and enhanced anesthesia
CA2495412A1 (en) * 2002-08-16 2004-02-26 Pharmacia & Upjohn Company 5 androsten-3.beta.-ol steroid intermediates and processes for their preparation
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
WO2014169832A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
MX362543B (es) 2013-04-17 2019-01-24 Sage Therapeutics Inc Esteroides c21-n-pirazolilo 19-nor c3,3- disustituidos y metodos de uso de los mismos.
HRP20210610T1 (hr) 2013-07-19 2021-05-28 Sage Therapeutics, Inc. Neuroaktivni steroidi, pripravci i njihove uporabe
PT3035940T (pt) 2013-08-23 2019-01-28 Sage Therapeutics Inc Esteroides neuroativos, composições e seus usos
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP3885352B1 (en) 2014-10-16 2024-11-27 Sage Therapeutics, Inc. A compound, compositions thereof and this compound for use in methods of treating cns disorders
EP4275748A3 (en) 2014-10-16 2024-01-03 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
RS60343B1 (sr) 2014-11-27 2020-07-31 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns-a
SMT202100113T1 (it) 2015-01-26 2021-05-07 Sage Therapeutics Inc Composizioni e metodi per trattare disturbi del snc
EP3258939B1 (en) 2015-02-20 2022-09-07 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
AU2017296295B2 (en) 2016-07-11 2022-02-24 Sage Therapeutics, Inc. C7, C12, and C16 substituted neuroactive steroids and their methods of use
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
AU2018392093B2 (en) * 2017-12-22 2024-02-01 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
US11718642B2 (en) * 2018-01-12 2023-08-08 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
TW202521129A (zh) 2018-12-05 2025-06-01 美商賽吉醫療公司 神經活性類固醇及其使用方法
KR102821994B1 (ko) * 2019-01-08 2025-06-19 쳉두 캉홍 파마슈티칼 코., 엘티디. 스테로이드 화합물, 및 이의 용도와 제조방법
AR119047A1 (es) 2019-05-31 2021-11-17 Sage Therapeutics Inc Esteroides neuroactivos como moduladores de gabaa y su uso en el tratamiento de trastornos del snc
CN114787174A (zh) * 2019-06-27 2022-07-22 萨奇治疗股份有限公司 用于治疗cns病症的组合物和方法
CA3143545A1 (en) * 2019-06-27 2020-12-30 Sage Therapeutics, Inc. Compounds for treating cns disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876705A (en) * 1972-06-12 1975-04-08 Univ New Brunswick Steroid total synthesis and intermediates

Also Published As

Publication number Publication date
AU501685B2 (en) 1979-06-28
DK588775A (da) 1976-06-24
CA1051868A (en) 1979-04-03
SE7514514L (sv) 1976-06-24
IL48628A0 (en) 1976-02-29
GB1538869A (en) 1979-01-24
NL7514976A (nl) 1976-06-25
DK138501B (da) 1978-09-18
DD123329A5 (enExample) 1976-12-12
AU8763775A (en) 1977-06-23
FR2295739A1 (fr) 1976-07-23
LU74087A1 (enExample) 1976-07-20
DK138501C (da) 1979-02-19
JPS5188953A (en) 1976-08-04
US4056633A (en) 1977-11-01

Similar Documents

Publication Publication Date Title
ES443825A1 (es) Procedimiento para la preparacion de d-homoroceto-pregna- nos.
ES455804A1 (es) Un procedimiento de preparacion de nuevos derivados del aci-do 3-quinolein- carboxilico.
ES464193A1 (es) Procedimiento para la preparacion de espirolactonas.
ES455149A1 (es) Procedimiento para preparar n-fenil-n'-benzoil-ureas.
ES471805A1 (es) Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3 - alcohilenaminopropanos, racemicos u opticamente activos
ES433145A1 (es) Procedimiento para preparar derivados de fenoxipropilamina.
ES481065A1 (es) Procedimiento para la preparacion de nuevos eteres 3-hidroxidifenilicos halogenados.
GB2191196B (en) Imidazo pyrimidines
GR82123B (enExample)
ES457385A1 (es) Procedimiento para preparar derivados de prostaglandinas.
IE800968L (en) Pyrazinobenzodiazepines
ES481551A1 (es) Procedimiento de preparacion de nuevos compuestos bis (ari- loxicarboxilicos).
ES474543A1 (es) Procedimiento para producir derivados del acido propionico.
ES440395A1 (es) Procedimiento para la produccion de esteres de acidos piri- midiniltionofosfonicos.
ES439038A1 (es) Procedimiento para la preparacion de nuevas isoquinoleinas.
ES8101081A1 (es) Procedimiento de preparacion de nuevos derivados acetileni- cos del androst-4-eno.
ES443536A1 (es) Procedimiento para la obtencion de composiciones herbicidas.
ES435622A1 (es) Procedimiento para la preparacion de bencenosulfonifurcas.
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
CA1273946C (en) ANTICONVULSANT GAMMA-THIOBUTYROLACTONE DERIVATIVES
ES466682A1 (es) Procedimiento para la obtencion de derivados del acido inde-no - 2.1-b-tiopen-2-oxamico
ES448989A1 (es) Procedimiento para la obtencion de derivados alquinicos.
ES438513A1 (es) Procedimiento para la obtencion de derivados de hexahidro- diazepino-indol.
EP0044266A3 (en) Substituted 3,5-diamino-1,2,4-oxadiazoles and 3,5-diamino-1,2,4-thiadiazoles, their preparation and use
ES474218A1 (es) Procedimiento para la preparacion de nuevas 4-fenil-tieno-( 2,3-c )-piperidinas